AU2014205123B2 - Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type 1 diabetes applications - Google Patents

Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type 1 diabetes applications Download PDF

Info

Publication number
AU2014205123B2
AU2014205123B2 AU2014205123A AU2014205123A AU2014205123B2 AU 2014205123 B2 AU2014205123 B2 AU 2014205123B2 AU 2014205123 A AU2014205123 A AU 2014205123A AU 2014205123 A AU2014205123 A AU 2014205123A AU 2014205123 B2 AU2014205123 B2 AU 2014205123B2
Authority
AU
Australia
Prior art keywords
zone
insulin
controller
day
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014205123A
Other languages
English (en)
Other versions
AU2014205123A1 (en
Inventor
Eyal Dassau
Francis J. Doyle Iii
Ravi L. Gondhalekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California, San Diego filed Critical University of California
Publication of AU2014205123A1 publication Critical patent/AU2014205123A1/en
Application granted granted Critical
Publication of AU2014205123B2 publication Critical patent/AU2014205123B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • External Artificial Organs (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2014205123A 2013-01-14 2014-01-14 Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type 1 diabetes applications Active AU2014205123B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751942P 2013-01-14 2013-01-14
US61/751,942 2013-01-14
PCT/US2014/011378 WO2014110541A1 (en) 2013-01-14 2014-01-14 Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications

Publications (2)

Publication Number Publication Date
AU2014205123A1 AU2014205123A1 (en) 2015-07-30
AU2014205123B2 true AU2014205123B2 (en) 2018-08-16

Family

ID=51165703

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014205123A Active AU2014205123B2 (en) 2013-01-14 2014-01-14 Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type 1 diabetes applications

Country Status (8)

Country Link
US (1) US10507284B2 (enExample)
EP (1) EP2943150B1 (enExample)
JP (1) JP6810989B2 (enExample)
KR (1) KR102212020B1 (enExample)
CN (1) CN105050539B (enExample)
AU (1) AU2014205123B2 (enExample)
CA (1) CA2897925C (enExample)
WO (1) WO2014110541A1 (enExample)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7972296B2 (en) 2007-10-10 2011-07-05 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
EP3594961A1 (en) 2010-10-31 2020-01-15 Trustees of Boston University Blood glucose control system
WO2014172467A1 (en) 2013-04-16 2014-10-23 Smartloop Llc Discretionary insulin delivery systems and methods
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
WO2015116524A1 (en) 2014-01-31 2015-08-06 Trustees Of Boston University Offline glucose control based on preceding periods
AU2015301146B2 (en) * 2014-08-06 2020-06-25 Regents Of The University Of California Moving-horizon state-initializer for control applications
DE102015000845A1 (de) * 2015-01-27 2016-07-28 W.O.M. World Of Medicine Gmbh Verfahren und Vorrichtung zur Regelung der Temperatur des Gasstroms bei medizintechnischen Vorrichtungen
CA2977053C (en) 2015-02-18 2023-08-01 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
EP3319511B1 (en) 2015-08-07 2021-10-06 Trustees of Boston University Glucose control system with automatic adaptation of glucose target
WO2017070553A1 (en) * 2015-10-21 2017-04-27 University Of Virginia Patent Foundation System, method and computer readable medium for dynamical tracking of the risk for hypoglycemia in type 1 and type 2 diabetes
JP6957509B2 (ja) * 2016-01-12 2021-11-02 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 過去の予測を使用する人工膵臓のための予測制御モデル
EP3374905A1 (en) 2016-01-13 2018-09-19 Bigfoot Biomedical, Inc. User interface for diabetes management system
EP4545005A3 (en) 2016-01-14 2025-07-02 Insulet Corporation Adjusting insulin delivery rates
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
AU2017216336B2 (en) 2016-02-05 2020-12-10 Animas Corporation Visualization and analysis tool for a drug delivery system
EP3451926B1 (en) 2016-05-02 2024-12-11 DexCom, Inc. System for providing alerts optimized for a user
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
WO2018009614A1 (en) 2016-07-06 2018-01-11 President And Fellows Of Harvard College Event-triggered model predictive control for embedded artificial pancreas systems
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP4708310A3 (en) 2017-01-13 2026-05-06 Insulet Corporation Insulin delivery methods, systems and devices
EP4708311A3 (en) 2017-01-13 2026-05-20 Insulet Corporation METHODS, SYSTEMS AND DEVICES FOR INSULIN ADMINISTRATION
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11497851B2 (en) * 2017-03-31 2022-11-15 Lifescan Ip Holdings, Llc Maintaining maximum dosing limits for closed loop insulin management systems
US11147920B2 (en) 2017-04-18 2021-10-19 Lifescan Ip Holdings, Llc Diabetes management system with automatic basal and manual bolus insulin control
CA3059985C (en) 2017-05-05 2023-08-08 Eli Lilly And Company Closed loop control of physiological glucose
US12161463B2 (en) 2017-06-09 2024-12-10 President And Fellows Of Harvard College Prevention of post-bariatric hypoglycemia using a novel glucose prediction algorithm and mini-dose stable glucagon
US12653426B2 (en) 2017-07-13 2026-06-16 Bigfoot Biomedical, Inc. Multi-scale display of blood glucose information
EP4765154A2 (en) 2017-08-02 2026-06-24 Diabeloop Closed-loop blood glucose control systems and methods
JP7133625B2 (ja) 2017-12-21 2022-09-08 イーライ リリー アンド カンパニー 生理的グルコースの閉ループ制御
JP7443235B2 (ja) 2018-02-09 2024-03-05 デックスコム・インコーポレーテッド 意思決定支援のシステムおよび方法
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11147919B2 (en) 2018-04-23 2021-10-19 Medtronic Minimed, Inc. Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system
US11158413B2 (en) 2018-04-23 2021-10-26 Medtronic Minimed, Inc. Personalized closed loop medication delivery system that utilizes a digital twin of the patient
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
US12128212B2 (en) 2018-06-19 2024-10-29 President And Fellows Of Harvard College Adaptive zone model predictive control with a glucose and velocity dependent dynamic cost function for an artificial pancreas
CN112313754A (zh) 2018-06-22 2021-02-02 伊莱利利公司 胰岛素和普兰林肽输送系统、方法和设备
US11547799B2 (en) 2018-09-20 2023-01-10 Medtronic Minimed, Inc. Patient day planning systems and methods
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
WO2020077223A1 (en) 2018-10-11 2020-04-16 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11986629B2 (en) 2019-06-11 2024-05-21 Medtronic Minimed, Inc. Personalized closed loop optimization systems and methods
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
JP7657428B2 (ja) 2019-07-16 2025-04-07 ベータ バイオニクス，インコーポレイテッド 血糖制御システム
MX2022000670A (es) 2019-07-16 2022-05-20 Beta Bionics Inc Sistema de control de glucosa en sangre.
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4354455B1 (en) 2019-12-06 2025-10-29 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
WO2021141941A1 (en) 2020-01-06 2021-07-15 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
WO2021158580A1 (en) 2020-02-03 2021-08-12 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
CN111710009B (zh) * 2020-05-29 2023-06-23 北京百度网讯科技有限公司 人流密度的生成方法、装置、电子设备以及存储介质
US12121700B2 (en) 2020-07-22 2024-10-22 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
US12115351B2 (en) 2020-09-30 2024-10-15 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
EP4696344A3 (en) 2020-09-30 2026-04-15 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
KR102521085B1 (ko) * 2020-10-30 2023-04-12 이오플로우(주) 인슐린 패치를 포함하는 인공췌장 제어 방법 및 그 장치
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
EP4285376A1 (en) 2021-01-29 2023-12-06 Insulet Corporation Techniques and devices that adapt basal profiles for drug delivery applications
US20220273874A1 (en) * 2021-02-24 2022-09-01 University Of Virginia Patent Foundation Method and system of fully-automated artificial pancreas control for counteracting postprandial hyperglycemia
US12636435B2 (en) 2021-02-26 2026-05-26 Insulet Corporation Techniques for optimizing usage of an automatic drug delivery system
WO2022192482A1 (en) 2021-03-10 2022-09-15 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
USD1127405S1 (en) 2021-03-25 2026-05-26 Beta Bionics, Inc. Clip for bionic pancreas infusion pump cases
US12465686B2 (en) 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (en) 2021-06-07 2022-12-14 Insulet Corporation Exercise safety prediction based on physiological conditions
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
US12653949B2 (en) 2021-07-29 2026-06-16 Insulet Corporation Adaptation of medicament delivery in response to user stress load
EP4409581A1 (en) 2021-09-27 2024-08-07 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
WO2023150737A1 (en) 2022-02-07 2023-08-10 Insulet Corporation Techniques for determining medication correction factors in automatic medication delivery systems
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
EP4511843A1 (en) 2022-04-21 2025-02-26 Insulet Corporation Insulin adaptation and safety monitoring for sick day management
KR20250129777A (ko) 2023-01-06 2025-08-29 인슐렛 코포레이션 후속 자동 안전 제약 완화를 갖는 자동으로 또는 수동으로 개시되는 음식 볼러스 전달
CN119480135B (zh) * 2024-11-08 2025-10-10 北京理工大学 基于未知外源输入估计的餐后长时间窗血糖态势预测方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100145262A1 (en) * 2007-05-03 2010-06-10 Novo Nordisk A/S Safety system for insulin delivery advisory algorithms
US20110106049A1 (en) * 2005-05-13 2011-05-05 Trustees Of Boston University Fully automated control system for type 1 diabetes
WO2012051344A2 (en) * 2010-10-12 2012-04-19 Regents Of The University Of California, The Maintaining multiple defined physiological zones using model predictive control

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6740072B2 (en) * 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US8152789B2 (en) * 2001-10-23 2012-04-10 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US7591801B2 (en) * 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US9056165B2 (en) * 2006-09-06 2015-06-16 Medtronic Minimed, Inc. Intelligent therapy recommendation algorithm and method of using the same
US20080234943A1 (en) * 2007-03-20 2008-09-25 Pinaki Ray Computer program for diabetes management
SI2518655T1 (sl) * 2007-06-21 2020-02-28 F. Hoffmann-La Roche Ag Pripomoček in metoda za preprečevanje hipoglikemije
JP2010531707A (ja) * 2007-06-25 2010-09-30 メディンゴ・リミテッド 適合された基礎インスリン送達システム
EP3881874A1 (en) * 2008-09-15 2021-09-22 DEKA Products Limited Partnership Systems and methods for fluid delivery
EP2413781B1 (en) * 2009-03-31 2019-07-24 Abbott Diabetes Care Inc. Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model
US9486578B2 (en) * 2012-12-07 2016-11-08 Animas Corporation Method and system for tuning a closed-loop controller for an artificial pancreas

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110106049A1 (en) * 2005-05-13 2011-05-05 Trustees Of Boston University Fully automated control system for type 1 diabetes
US20100145262A1 (en) * 2007-05-03 2010-06-10 Novo Nordisk A/S Safety system for insulin delivery advisory algorithms
WO2012051344A2 (en) * 2010-10-12 2012-04-19 Regents Of The University Of California, The Maintaining multiple defined physiological zones using model predictive control

Also Published As

Publication number Publication date
US10507284B2 (en) 2019-12-17
KR20150108860A (ko) 2015-09-30
AU2014205123A1 (en) 2015-07-30
JP6810989B2 (ja) 2021-01-13
EP2943150B1 (en) 2018-12-05
WO2014110541A1 (en) 2014-07-17
CA2897925A1 (en) 2014-07-17
KR102212020B1 (ko) 2021-02-05
EP2943150A1 (en) 2015-11-18
CN105050539A (zh) 2015-11-11
EP2943150A4 (en) 2016-10-26
US20140200559A1 (en) 2014-07-17
CA2897925C (en) 2017-05-30
CN105050539B (zh) 2018-05-18
JP2016504119A (ja) 2016-02-12

Similar Documents

Publication Publication Date Title
CA2897925C (en) Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type 1 diabetes applications
Grosman et al. Zone model predictive control: a strategy to minimize hyper-and hypoglycemic events
Gondhalekar et al. Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes
Kovatchev et al. Control to range for diabetes: functionality and modular architecture
JP6378164B2 (ja) 血糖制御システム
León-Vargas et al. Postprandial blood glucose control using a hybrid adaptive PD controller with insulin-on-board limitation
DK2628115T3 (en) Insulin Delivery Device
WO2018009614A1 (en) Event-triggered model predictive control for embedded artificial pancreas systems
CN104885086A (zh) 对人工胰腺进行混合式“控制到目标”和“控制到范围”模型预测控制的方法和系统
Toffanin et al. Automatic adaptation of basal therapy for type 1 diabetic patients: a run-to-run approach
Resalat et al. Adaptive tuning of basal and bolus insulin to reduce postprandial hypoglycemia in a hybrid artificial pancreas
Cescon et al. Using iterative learning for insulin dosage optimization in multiple-daily-injections therapy for people with type 1 diabetes
Batora et al. Bihormonal control of blood glucose in people with type 1 diabetes
Mirzaee et al. A nonlinear MPC approach for blood glucose regulation in diabetic patients
CN110352460A (zh) 人工胰腺
Messori et al. A constrained model predictive controller for an artificial pancreas
Bequette Challenges and progress in the development of a closed-loop artificial pancreas
Incremona et al. Artificial pancreas: from control-to-range to control-to-target
Ata et al. Model based control of artificial pancreas under meal disturbances
Caponetto et al. Control of fractional order bergman’s glucose-insulin minimal model
Boiroux Model predictive control algorithms for pen and pump insulin administration
Patek et al. Anticipating meals with behavioral profiles: towards stochastic model predictive control of t1dm
Rachim et al. Fully Automated Insulin Delivery Algorithm with Modular-Deep Reinforcement Learning Control and Personalized Decision Support
Chakrabarty et al. Reducing controller updates via event-triggered model predictive control in an embedded artificial pancreas
Grosman et al. Model-based sensor-augmented pump therapy

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ DOYLE III, FRANCIS J.; DASSAU, EYAL AND GONDHALEKAR, RAVI L.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted
NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO GAIN ACCEPTANCE HAS BEEN EXTENDED TO 21 AUG 2018

FGA Letters patent sealed or granted (standard patent)